Abstract
L’insufficienza renale cronica (IRC) è una patologia in progressivo incremento; in Italia circa 3 milioni le persone affette da IRC agli stadi 3-5 sec. K-DOQI, ma una percentuale inferiore al 30% dei soggetti agli stadi 4-5 sarebbe nota presso gli ambulatori nefrologici. A fronte di questa evidenza, che riflette importanti implicazioni nell’ambito della prevenzione primaria, si rilevano, il più delle volte, importanti difficoltà comunicative tra medico di medicina generale (MMG) e specialista nefrologo, in merito soprattutto alla tempistica e alle modalità di follow-up di questi pazienti. Alla luce di questo, abbiamo elaborato un Glossario che include informazioni riguardo all’approccio diagnostico e terapeutico delle complicanze dell’IRC, al fine di identificare precocemente le più frequenti anomalie metaboliche e di ottimizzare la tempistica dei controlli ambulatoriali.
Introduction: Bridging the Communication Gap
Chronic Kidney Disease (CKD) represents a growing public health challenge in Italy, affecting approximately 3 million individuals in stages 3-5. Despite the severity of the condition, a significant gap exists in specialist care: fewer than 30% of patients in advanced stages (4-5) are currently followed by nephrology clinics. This discrepancy highlights a critical need for improved communication and standardized protocols between General Practitioners (GPs) and nephrologists.
Standardizing CKD Staging
A primary hurdle in managing CKD is the inconsistent application of staging criteria. The authors advocate for the universal adoption of the K-DOQI classification system, which categorizes disease severity based on the Glomerular Filtration Rate (GFR) and the presence of albuminuria. This standardization allows for a shared language between primary and specialist care, ensuring that patients are referred and monitored according to their actual risk profile.
The "Creatinine Trap" and GFR Estimation
A common pitfall in primary care is the over-reliance on serum creatinine as a standalone marker of kidney health. As illustrated by the MDRD study data, serum creatinine levels can remain within the "normal" range even when a patient has lost a substantial portion of their renal function. By the time creatinine significantly rises, the GFR may have already dropped to dangerously low levels. This "silent" decline underscores the importance of using estimated GFR (eGFR) formulas like MDRD or CKD-EPI for routine screening.
Clinical Management and Follow-up
The proposed "Glossary" provides a structured framework for the early identification of metabolic complications, such as anemia, hyperparathyroidism, and electrolyte imbalances. The authors highlight that these specific alterations increase sharply as GFR drops below 60 mL/min. Key management strategies include:
- Follow-up Intervals: Defined based on disease stage (e.g., every 6-9 months for Stage 3, increasing to every 1.5 months for Stage 5).
- Metabolic Bone Disease: Monitoring Calcium, Phosphorus, and PTH to prevent arterial calcification and bone loss.
- Nutritional Therapy: Implementing specialized diets to control phosphorus and acidosis, potentially delaying the need for dialysis.
- Blood Pressure Control: Adhering to aggressive targets (e.g., <140/80 mmHg) to slow the progression of renal damage.
Conclusion
By providing a clear, educational tool for GPs, this glossary aims to transform CKD management from a reactive to a proactive model. Early intervention and timely referral to specialists are essential to reducing the burden of end-stage renal disease and improving patient outcomes across the healthcare system.
Summary updated